Tid Tittel Kategori Vedlegg
26.08.2026
07:00
Circio and Full Circles Therapeutics jointly announce in vivo cell therapy research - -
25.08.2026
18:35
Circio Holding ASA: Minutes from the extraordinary general meeting 25 August 2026 -
1
25.08.2026
07:00
Circio invites to live webcast on 1 September 2026 at 10:00 am CEST - -
06.08.2026
07:00
Circio selected to deliver oral presentation at the prestigious ESGCT annual meeting - -
04.08.2026
11:06
Circio nominates RNA and gene therapy US industry veteran Dr. Dinah Sah to its Board of Directors - -
04.08.2026
11:05
Circio Holding ASA Notice of extraordinary general meeting on 25 August 2026 -
1
16.07.2026
08:58
Circio and Avenue Biosciences jointly announce research collaboration to enhance protein secretion for gene therapy - -
24.06.2026
07:00
Circio and Tcelltech jointly announce CAR-T cell therapy research collaboration - -
22.06.2026
14:05
Circio Holding ASA Share capital increase registered - -
18.06.2026
11:02
CIRCIO HOLDING ASA SHARE CAPITAL INCREASE REGISTERED FOLLOWING EXERCISE OF WARRANTS AND UNDERWRITTEN PRIVATE PLACEMENT - -
15.06.2026
08:08
FLAGGMELDING for Høse AS STORAKSJONÆR AKS -
09.06.2026
23:12
Circio completes transformational fundraising of NOK 300 million to strengthen its position as the global leader in circular RNA-based gene expression systems INFORMASJON INF -
09.06.2026
07:00
Circio Holding ASA: Last day of the exercise period for the Warrants - -
04.06.2026
09:41
Circio Holding ASA Exercise of Warrants by primary insiders INSIDEHANDEL INS
1
03.06.2026
07:00
Circio Holding ASA: Last day of trading in warrants - -
02.06.2026
10:33
Circio Holding ASA Exercise of Warrants by primary insiders INSIDEHANDEL INS
1
01.06.2026
07:00
Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy - -
29.05.2026
07:00
Circio Holding ASA Exercise of Warrants by primary insiders INSIDEHANDEL INS
1
28.05.2026
07:00
Circio hosts live webcast today 28 May 2026 at 10:00 am CEST -
1
27.05.2026
07:00
Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases - -
26.05.2026
07:10
Announcement of the terms of the underwriting and the Unused Warrants Option Agreement in connection with the Warrant Program INFORMASJON INF -
26.05.2026
07:05
Commencement of exercise period for the Warrants - -
26.05.2026
07:00
Warrants exercise period commences today potential proceeds to transform Circio into a clinical-stage circular RNA company INFORMASJON INF -
22.05.2026
18:11
Circio Holding ASA: Exercise price for Warrants set at NOK 8.2508 - -
22.05.2026
07:00
Circio invites to a live webcast on 28 May 2026 to summarize the presentations at ASGCT 2026 and provide an overview of the warrants program - -